Drug intelligence / Profile preview

bordetella pertussis pertactin antigen (formaldehyde inactivated)

Development stage
Approved
Lead developer
Sanofi Pasteur
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Bordetella pertussis pertactin antigen (formaldehyde inactivated) is a vaccine component used in the prophylaxis of pertussis (whooping cough). It is one of several purified components of B. pertussis used in acellular pertussis vaccines. Pertactin is a virulence factor of B. pertussis that has been inactivated with formaldehyde for use in vaccines. This component is typically combined with other pertussis antigens (such as pertussis toxoid, filamentous hemagglutinin, and fimbriae) and often formulated with diphtheria and tetanus toxoids in combination vaccines like DTaP (Diphtheria, Tetanus, acellular Pertussis).

Brand names
BoostrixInfanrixKinrixPediarix
Other names
Inactivated Bordetella Pertussis Vaccine

Beyond the preview

Go deeper on bordetella pertussis pertactin antigen (formaldehyde inactivated).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bordetella pertussis pertactin antigen (formaldehyde inactivated).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call